TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM

TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM was reported 6755 times

TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCROTAL CELLULITIS 7 0.1228
1 PERINEAL CELLULITIS 7 0.1186
2 BURKHOLDERIA TEST POSITIVE 7 0.0565
3 SCROTAL ABSCESS 19 0.0503
4 NECROTISING SOFT TISSUE INFECTION 11 0.0476
5 GENITAL ABSCESS 19 0.0470
6 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 15 0.0369
7 PERINEAL ABSCESS 14 0.0310
8 NEPHRITIS INTERSTITIAL 36 0.0285
9 PERIRECTAL ABSCESS 22 0.0198
10 PULMONARY VASCULAR DISORDER 9 0.0191
11 WEANING FAILURE 6 0.0165
12 VITAMIN K DEFICIENCY 6 0.0149
13 ACQUIRED OESOPHAGEAL WEB 5 0.0147
14 TUMOUR ASSOCIATED FEVER 6 0.0147
15 SEPSIS SYNDROME 7 0.0139
16 GROIN ABSCESS 15 0.0127
17 ENTEROCOCCAL BACTERAEMIA 12 0.0113
18 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 12 0.0113
19 PSEUDOMEMBRANOUS COLITIS 25 0.0112
20 ENTEROCOCCAL SEPSIS 9 0.0111
21 DRY GANGRENE 7 0.0110
22 APNOEIC ATTACK 6 0.0106
23 SPUTUM CULTURE POSITIVE 8 0.0099
24 JARISCH-HERXHEIMER REACTION 7 0.0098
25 NECROTISING FASCIITIS 34 0.0096
26 RENAL TUBULAR NECROSIS 94 0.0096
27 PNEUMONIA STAPHYLOCOCCAL 18 0.0091
28 DEBRIDEMENT 7 0.0091
29 ENTEROCUTANEOUS FISTULA 8 0.0091
30 CATHETER RELATED INFECTION 9 0.0089
31 KLEBSIELLA SEPSIS 10 0.0089
32 DISSEMINATED INTRAVASCULAR COAGULATION 125 0.0089
33 BACTERIURIA 5 0.0088
34 DYSPNOEA PAROXYSMAL NOCTURNAL 6 0.0082
35 NEPHROGENIC ANAEMIA 38 0.0082
36 TRANSFUSION REACTION 7 0.0080
37 HYPERPARATHYROIDISM SECONDARY 20 0.0080
38 RHONCHI 11 0.0080
39 RED MAN SYNDROME 7 0.0080
40 ANAEMIA OF CHRONIC DISEASE 7 0.0077
41 BLAST CELL COUNT INCREASED 8 0.0076
42 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 6 0.0076
43 SYSTEMIC CANDIDA 19 0.0076
44 CHRONIC RESPIRATORY FAILURE 9 0.0075
45 ACINETOBACTER INFECTION 8 0.0073
46 ISCHAEMIC HEPATITIS 10 0.0073
47 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
48 CONTINUOUS HAEMODIAFILTRATION 7 0.0072
49 PYURIA 7 0.0071
50 ENTERITIS INFECTIOUS 12 0.0070
51 FUNGAEMIA 11 0.0070
52 PELVIC ABSCESS 8 0.0070
53 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
54 HEPARIN-INDUCED THROMBOCYTOPENIA 34 0.0069
55 AORTIC VALVE SCLEROSIS 5 0.0068
56 HYPERNATRAEMIA 34 0.0068
57 METABOLIC ENCEPHALOPATHY 20 0.0067
58 GALLBLADDER ENLARGEMENT 7 0.0065
59 CLOSTRIDIAL INFECTION 22 0.0065
60 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 9 0.0064
61 LEFT ATRIAL DILATATION 8 0.0063
62 MASTOIDITIS 6 0.0061
63 COLON ADENOMA 6 0.0061
64 ANAEMIA HAEMOLYTIC AUTOIMMUNE 5 0.0060
65 MULTI-ORGAN FAILURE 102 0.0059
66 ABSCESS LIMB 25 0.0059
67 ELECTROCARDIOGRAM T WAVE ABNORMAL 9 0.0058
68 LUNG CONSOLIDATION 16 0.0057
69 ACUTE RESPIRATORY FAILURE 108 0.0056
70 CLOSTRIDIUM TEST POSITIVE 12 0.0054
71 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
72 ATELECTASIS 52 0.0054
73 ASPERGILLOSIS 7 0.0054
74 PNEUMONIA FUNGAL 21 0.0053
75 PULSELESS ELECTRICAL ACTIVITY 22 0.0053
76 PNEUMONIA BACTERIAL 48 0.0052
77 PNEUMONIA PSEUDOMONAL 8 0.0052
78 CARBON DIOXIDE DECREASED 6 0.0052
79 RENAL FAILURE ACUTE 219 0.0052
80 DILATATION ATRIAL 6 0.0051
81 SYSTEMIC MYCOSIS 6 0.0051
82 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 26 0.0051
83 HYPERPHOSPHATAEMIA 11 0.0051
84 EOSINOPHILIC PNEUMONIA 16 0.0051
85 ANAL ABSCESS 27 0.0050
86 ECHOCARDIOGRAM ABNORMAL 7 0.0050
87 CULTURE URINE POSITIVE 7 0.0050
88 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
89 CLOSTRIDIUM COLITIS 6 0.0049
90 SOFT TISSUE INFECTION 9 0.0049
91 STAPHYLOCOCCAL SEPSIS 24 0.0049
92 VASCULAR DEVICE INFECTION 22 0.0048
93 MECHANICAL VENTILATION 9 0.0047
94 NEPHROPATHY TOXIC 53 0.0047
95 BRONCHIAL SECRETION RETENTION 6 0.0047
96 LUNG INFILTRATION 41 0.0046
97 HYPERURICAEMIA 19 0.0046
98 PYELONEPHRITIS ACUTE 9 0.0046
99 CLOSTRIDIUM DIFFICILE COLITIS 48 0.0045
100 HAEMOTHORAX 13 0.0045
101 LEFT VENTRICULAR HYPERTROPHY 19 0.0044
102 LEUKOCYTOSIS 80 0.0044
103 CHOLECYSTITIS ACUTE 25 0.0044
104 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7 0.0044
105 PROTHROMBIN TIME PROLONGED 26 0.0043
106 ENTEROCOCCAL INFECTION 21 0.0043
107 PNEUMOPERITONEUM 8 0.0043
108 ACUTE PRERENAL FAILURE 5 0.0043
109 LOBAR PNEUMONIA 8 0.0043
110 HYPERCAPNIA 13 0.0043
111 ABDOMINAL INFECTION 11 0.0043
112 LEUKOCYTOCLASTIC VASCULITIS 7 0.0043
113 SEPTIC SHOCK 185 0.0042
114 VENA CAVA THROMBOSIS 7 0.0042
115 PSEUDOMONAS INFECTION 36 0.0042
116 RECTAL ABSCESS 7 0.0042
117 RENAL FAILURE CHRONIC 32 0.0042
118 BACTERAEMIA 49 0.0041
119 ACUTE RESPIRATORY DISTRESS SYNDROME 73 0.0041
120 FOOT AMPUTATION 6 0.0041
121 SEPSIS 460 0.0041
122 PNEUMONIA CYTOMEGALOVIRAL 8 0.0041
123 ORTHOPNOEA 13 0.0041
124 RESPIRATORY ACIDOSIS 16 0.0041
125 BLOOD CHLORIDE INCREASED 7 0.0040
126 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 24 0.0040
127 FAILURE TO THRIVE 21 0.0040
128 BACTERIAL TEST POSITIVE 9 0.0040
129 SPONDYLOLISTHESIS 7 0.0040
130 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0040
131 KLEBSIELLA INFECTION 20 0.0040
132 FEBRILE NEUTROPENIA 260 0.0039
133 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
134 DRUG MONITORING PROCEDURE NOT PERFORMED 7 0.0039
135 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
136 TOXIC EPIDERMAL NECROLYSIS 59 0.0039
137 NEUTROPENIC COLITIS 8 0.0039
138 NEUROGENIC BLADDER 8 0.0038
139 SUBCUTANEOUS ABSCESS 18 0.0038
140 MENTAL STATUS CHANGES 104 0.0037
141 HISTIOCYTOSIS HAEMATOPHAGIC 11 0.0037
142 ENDOCARDITIS 19 0.0037
143 SPUTUM INCREASED 8 0.0037
144 BLOOD CULTURE POSITIVE 11 0.0037
145 PERIPHERAL ISCHAEMIA 15 0.0037
146 BLOOD ALBUMIN DECREASED 29 0.0037
147 PNEUMONIA ASPIRATION 91 0.0036
148 ISCHAEMIC CARDIOMYOPATHY 11 0.0036
149 END STAGE RENAL DISEASE 65 0.0036
150 DECUBITUS ULCER 29 0.0036
151 DYSLIPIDAEMIA 18 0.0035
152 APPENDICITIS PERFORATED 9 0.0035
153 CHOLECYSTITIS 42 0.0035
154 HEPATIC FUNCTION ABNORMAL 131 0.0035
155 HYPOXIA 123 0.0035
156 THROMBOTIC MICROANGIOPATHY 34 0.0035
157 BLOOD UREA INCREASED 58 0.0035
158 BILE DUCT STONE 11 0.0035
159 RESPIRATORY FAILURE 252 0.0035
160 HAEMODIALYSIS 29 0.0034
161 CYTOKINE RELEASE SYNDROME 69 0.0034
162 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
163 BILIARY DILATATION 5 0.0034
164 ACIDOSIS 26 0.0034
165 KYPHOSIS 6 0.0034
166 LIVER ABSCESS 11 0.0034
167 BACTERIAL SEPSIS 11 0.0034
168 FIBRIN D DIMER INCREASED 12 0.0034
169 JUGULAR VEIN THROMBOSIS 6 0.0034
170 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
171 INTRA-ABDOMINAL HAEMORRHAGE 8 0.0034
172 INTRA-ABDOMINAL FLUID COLLECTION 6 0.0033
173 LIVER TRANSPLANT REJECTION 6 0.0033
174 LUNG ABSCESS 7 0.0033
175 DILATATION VENTRICULAR 7 0.0033
176 GANGRENE 20 0.0033
177 CENTRAL VENOUS CATHETERISATION 10 0.0033
178 BLOOD PHOSPHORUS INCREASED 9 0.0033
179 CHOLANGITIS 20 0.0032
180 MULTIPLE MYELOMA 15 0.0032
181 HYPOALBUMINAEMIA 25 0.0032
182 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
183 HYPERTENSIVE HEART DISEASE 6 0.0032
184 URINE OUTPUT DECREASED 28 0.0032
185 SMALL INTESTINAL PERFORATION 6 0.0032
186 INFECTED SKIN ULCER 6 0.0032
187 DIALYSIS 45 0.0032
188 EXCORIATION 8 0.0032
189 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 17 0.0031
190 ESCHERICHIA SEPSIS 9 0.0031
191 ADENOVIRUS INFECTION 9 0.0031
192 INTESTINAL ISCHAEMIA 17 0.0031
193 CYSTIC FIBROSIS 17 0.0031
194 THERAPEUTIC AGENT TOXICITY 10 0.0030
195 DRUG ERUPTION 53 0.0030
196 CHOLECYSTITIS CHRONIC 20 0.0030
197 BLOOD ALKALINE PHOSPHATASE INCREASED 74 0.0030
198 CYSTITIS HAEMORRHAGIC 12 0.0030
199 CARDIAC VALVE DISEASE 17 0.0030
200 THROMBOPHLEBITIS SUPERFICIAL 9 0.0030
201 BLOOD SODIUM INCREASED 8 0.0030
202 DIVERTICULUM 21 0.0030
203 RENAL HAEMORRHAGE 6 0.0029
204 ENTEROCOLITIS 17 0.0029
205 ABDOMINAL ABSCESS 13 0.0029
206 OSTEOLYSIS 6 0.0029
207 CHEST X-RAY ABNORMAL 9 0.0029
208 BLOOD CREATININE INCREASED 190 0.0029
209 CAPILLARY LEAK SYNDROME 6 0.0029
210 HAEMOLYTIC ANAEMIA 26 0.0029
211 PANCYTOPENIA 162 0.0029
212 HYPERBILIRUBINAEMIA 30 0.0029
213 STEVENS-JOHNSON SYNDROME 64 0.0029
214 TACHYPNOEA 39 0.0029
215 CAROTID ARTERY STENOSIS 10 0.0029
216 MALNUTRITION 32 0.0029
217 VENTRICULAR TACHYCARDIA 47 0.0028
218 HYPOKALAEMIA 131 0.0028
219 RETROPERITONEAL HAEMORRHAGE 7 0.0028
220 SPINAL CORD COMPRESSION 11 0.0028
221 HAEMATOCRIT DECREASED 56 0.0028
222 STEM CELL TRANSPLANT 7 0.0028
223 DUODENAL ULCER HAEMORRHAGE 8 0.0028
224 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
225 GRAFT VERSUS HOST DISEASE 20 0.0028
226 TRICUSPID VALVE INCOMPETENCE 22 0.0028
227 PRODUCT CONTAMINATION PHYSICAL 7 0.0028
228 HYPOVOLAEMIA 16 0.0027
229 ASPARTATE AMINOTRANSFERASE INCREASED 145 0.0027
230 OTITIS MEDIA 9 0.0027
231 PERIPHERAL VASCULAR DISORDER 14 0.0027
232 FEAR OF DEATH 6 0.0027
233 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
234 PLEURAL EFFUSION 161 0.0026
235 BREATH SOUNDS ABNORMAL 13 0.0026
236 BILE DUCT OBSTRUCTION 5 0.0026
237 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
238 INTERSTITIAL LUNG DISEASE 127 0.0026
239 FLUID OVERLOAD 38 0.0026
240 CARDIOMEGALY 32 0.0026
241 UROSEPSIS 24 0.0026
242 ASPERGILLUS INFECTION 17 0.0026
243 AORTIC STENOSIS 9 0.0026
244 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
245 OLIGURIA 16 0.0026
246 NEUTROPHIL COUNT DECREASED 105 0.0026
247 GASTRIC PERFORATION 7 0.0026
248 MITRAL VALVE INCOMPETENCE 29 0.0026
249 LEFT VENTRICULAR DYSFUNCTION 17 0.0025
250 RESPIRATORY DISTRESS 70 0.0025
251 PULSE ABSENT 12 0.0025
252 PULMONARY FUNCTION TEST DECREASED 11 0.0025
253 RENAL FAILURE 333 0.0025
254 ENDOTRACHEAL INTUBATION 7 0.0025
255 ILEUS 31 0.0025
256 OSTEOMYELITIS 45 0.0025
257 ECCHYMOSIS 17 0.0025
258 PANCREATIC CARCINOMA METASTATIC 7 0.0025
259 CELLULITIS 124 0.0025
260 LARGE INTESTINE PERFORATION 17 0.0024
261 SMALL INTESTINAL OBSTRUCTION 30 0.0024
262 INTERNATIONAL NORMALISED RATIO INCREASED 69 0.0024
263 CATHETER SITE HAEMORRHAGE 6 0.0024
264 VENOOCCLUSIVE DISEASE 6 0.0024
265 ISCHAEMIA 11 0.0024
266 ACUTE KIDNEY INJURY 366 0.0024
267 ATRIAL FLUTTER 19 0.0024
268 CARDIOGENIC SHOCK 34 0.0024
269 BLOOD BILIRUBIN INCREASED 64 0.0024
270 PLEURISY 14 0.0024
271 AORTIC ARTERIOSCLEROSIS 6 0.0023
272 BLOOD CHLORIDE DECREASED 6 0.0023
273 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 6 0.0023
274 ALANINE AMINOTRANSFERASE INCREASED 142 0.0023
275 CATHETER SITE PAIN 6 0.0023
276 HYPOPHOSPHATAEMIA 17 0.0023
277 THROMBOCYTOPENIA 257 0.0023
278 UNRESPONSIVE TO STIMULI 59 0.0023
279 COAGULOPATHY 38 0.0023
280 EOSINOPHIL COUNT INCREASED 19 0.0023
281 LUNG OPACITY 6 0.0023
282 SERUM FERRITIN INCREASED 12 0.0023
283 AZOTAEMIA 9 0.0023
284 VENTRICULAR FIBRILLATION 25 0.0022
285 RHINITIS ALLERGIC 10 0.0022
286 ILEUS PARALYTIC 10 0.0022
287 HAEMODYNAMIC INSTABILITY 17 0.0022
288 RENAL IMPAIRMENT 187 0.0022
289 MULTIPLE INJURIES 14 0.0022
290 PLATELET COUNT DECREASED 233 0.0022
291 SINUS TACHYCARDIA 31 0.0022
292 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
293 PLEURITIC PAIN 6 0.0022
294 PATHOLOGICAL FRACTURE 11 0.0022
295 PNEUMONITIS 59 0.0022
296 NECROSIS 12 0.0022
297 MULTIPLE ORGAN DYSFUNCTION SYNDROME 61 0.0022
298 SERUM SICKNESS 6 0.0022
299 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 5 0.0021
300 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
301 RIGHT VENTRICULAR FAILURE 15 0.0021
302 NEUTROPHIL COUNT ABNORMAL 6 0.0021
303 SPINAL COLUMN STENOSIS 10 0.0021
304 ECONOMIC PROBLEM 32 0.0021
305 LUNG NEOPLASM 9 0.0021
306 CARDIAC TAMPONADE 10 0.0021
307 HEPATIC CYST 7 0.0021
308 GASTROINTESTINAL NECROSIS 6 0.0021
309 HEPATIC FAILURE 62 0.0021
310 RENAL INJURY 61 0.0021
311 ASCITES 60 0.0020
312 HEPATOMEGALY 20 0.0020
313 ORGANISING PNEUMONIA 10 0.0020
314 ANHEDONIA 53 0.0020
315 RENAL CYST 16 0.0020
316 AUTOIMMUNE HEPATITIS 14 0.0020
317 ASPIRATION 22 0.0020
318 MYELODYSPLASTIC SYNDROME 29 0.0020
319 NORMOCHROMIC NORMOCYTIC ANAEMIA 6 0.0020
320 HYPERKALAEMIA 70 0.0020
321 CANDIDIASIS 8 0.0020
322 EMBOLIC STROKE 7 0.0020
323 CARDIO-RESPIRATORY ARREST 83 0.0020
324 JAUNDICE CHOLESTATIC 7 0.0020
325 PYELONEPHRITIS 17 0.0020
326 PNEUMOTHORAX 31 0.0020
327 CARDIAC FAILURE ACUTE 13 0.0019
328 ARTHRITIS BACTERIAL 8 0.0019
329 EXTRAVASATION 8 0.0019
330 BRAIN DEATH 6 0.0019
331 NEUROTOXICITY 34 0.0019
332 EMBOLISM 16 0.0019
333 BLOOD PHOSPHORUS DECREASED 7 0.0019
334 ENCEPHALOPATHY 47 0.0019
335 PERICARDIAL EFFUSION 44 0.0019
336 PULMONARY OEDEMA 85 0.0019
337 AMYLASE INCREASED 7 0.0019
338 TESTICULAR PAIN 6 0.0019
339 PNEUMONIA VIRAL 6 0.0019
340 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
341 LEUKOENCEPHALOPATHY 7 0.0019
342 SHOCK 43 0.0019
343 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
344 CHRONIC SINUSITIS 7 0.0019
345 HAEMOPTYSIS 52 0.0019
346 ANURIA 16 0.0019
347 METASTATIC NEOPLASM 8 0.0019
348 HEPATIC LESION 8 0.0018
349 TROPONIN INCREASED 14 0.0018
350 DIVERTICULUM INTESTINAL 8 0.0018
351 EOSINOPHILIA 32 0.0018
352 SPINAL OSTEOARTHRITIS 16 0.0018
353 HYPERVOLAEMIA 9 0.0018
354 SUBDURAL HAEMATOMA 26 0.0018
355 ABDOMINAL TENDERNESS 9 0.0018
356 INJURY 127 0.0018
357 ARTERIOSCLEROSIS 17 0.0018
358 HAEMORRHAGE INTRACRANIAL 27 0.0018
359 LUNG INFECTION 28 0.0018
360 RHINOVIRUS INFECTION 7 0.0018
361 STREPTOCOCCAL INFECTION 10 0.0018
362 ACUTE MYELOID LEUKAEMIA 28 0.0018
363 HYPOMAGNESAEMIA 25 0.0018
364 SPLENOMEGALY 21 0.0018
365 WOUND SECRETION 7 0.0018
366 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
367 ABSCESS 28 0.0018
368 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
369 CREATININE RENAL CLEARANCE DECREASED 7 0.0017
370 WHITE BLOOD CELL COUNT INCREASED 67 0.0017
371 BLEPHARITIS 7 0.0017
372 ORGAN FAILURE 7 0.0017
373 GRANULOMA 6 0.0017
374 ELECTROLYTE IMBALANCE 20 0.0017
375 SHOCK HAEMORRHAGIC 14 0.0017
376 HEPATIC ENCEPHALOPATHY 16 0.0017
377 WHITE BLOOD CELL COUNT DECREASED 185 0.0017
378 TUMOUR LYSIS SYNDROME 15 0.0017
379 ANAPHYLACTOID REACTION 7 0.0017
380 GENERALISED OEDEMA 21 0.0017
381 DECREASED INTEREST 10 0.0017
382 LIVER DISORDER 75 0.0017
383 HAEMORRHAGIC DIATHESIS 6 0.0017
384 COMPRESSION FRACTURE 9 0.0017
385 HYPOGAMMAGLOBULINAEMIA 11 0.0017
386 PNEUMONIA 542 0.0017
387 HYPERLIPIDAEMIA 20 0.0017
388 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
389 AGRANULOCYTOSIS 31 0.0017
390 BONE LESION 6 0.0017
391 PULMONARY HAEMORRHAGE 13 0.0017
392 CHRONIC GRAFT VERSUS HOST DISEASE 6 0.0017
393 MONOCYTE COUNT INCREASED 6 0.0017
394 BUNDLE BRANCH BLOCK LEFT 7 0.0016
395 AORTIC VALVE INCOMPETENCE 7 0.0016
396 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
397 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
398 VENTRICULAR ARRHYTHMIA 6 0.0016
399 PURULENT DISCHARGE 7 0.0016
400 PULMONARY HYPERTENSION 34 0.0016
401 DEVICE RELATED INFECTION 25 0.0016
402 RASH GENERALISED 42 0.0016
403 HYPERCALCAEMIA 20 0.0016
404 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
405 ERYTHEMA MULTIFORME 15 0.0016
406 STAPHYLOCOCCAL INFECTION 53 0.0016
407 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
408 PANCREATITIS ACUTE 36 0.0016
409 JAUNDICE 43 0.0016
410 PROTEIN TOTAL DECREASED 6 0.0016
411 PYREXIA 551 0.0016
412 HYPOCALCAEMIA 30 0.0016
413 ABDOMINAL ADHESIONS 5 0.0016
414 TOXIC ENCEPHALOPATHY 8 0.0016
415 METABOLIC ACIDOSIS 50 0.0016
416 WOUND INFECTION 17 0.0016
417 RALES 9 0.0015
418 HYPOTENSION 310 0.0015
419 NEUTROPENIC SEPSIS 11 0.0015
420 BLOOD POTASSIUM INCREASED 25 0.0015
421 CARDIAC ARREST 127 0.0015
422 PATHOGEN RESISTANCE 14 0.0015
423 ACUTE GRAFT VERSUS HOST DISEASE 7 0.0015
424 CHOLELITHIASIS 50 0.0015
425 FEAR 41 0.0015
426 BLOOD CALCIUM DECREASED 17 0.0015
427 STATUS EPILEPTICUS 17 0.0015
428 CHRONIC KIDNEY DISEASE 114 0.0015
429 APPENDICITIS 14 0.0015
430 CARDIOMYOPATHY 22 0.0015
431 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
432 HYDRONEPHROSIS 11 0.0015
433 FAECAL INCONTINENCE 7 0.0015
434 MELAENA 32 0.0015
435 CORONARY ARTERY DISEASE 44 0.0015
436 SPINAL COMPRESSION FRACTURE 12 0.0014
437 BACTERIAL INFECTION 27 0.0014
438 CYTOMEGALOVIRUS INFECTION 24 0.0014
439 ORAL CANDIDIASIS 19 0.0014
440 RASH MACULO-PAPULAR 32 0.0014
441 ANAEMIA 274 0.0014
442 ACUTE PULMONARY OEDEMA 8 0.0014
443 HAEMOLYSIS 11 0.0014
444 BODY TEMPERATURE INCREASED 29 0.0014
445 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
446 GENERALISED ERYTHEMA 8 0.0014
447 INTERVERTEBRAL DISC DISORDER 6 0.0014
448 ADRENAL INSUFFICIENCY 17 0.0014
449 DEEP VEIN THROMBOSIS 91 0.0014
450 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0014
451 HIATUS HERNIA 18 0.0014
452 CARDIAC FAILURE CONGESTIVE 111 0.0014
453 TOE AMPUTATION 7 0.0014
454 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7 0.0014
455 POST PROCEDURAL HAEMORRHAGE 16 0.0014
456 HYPERGLYCAEMIA 50 0.0014
457 AMMONIA INCREASED 7 0.0014
458 HYPOPHAGIA 35 0.0014
459 PULMONARY CONGESTION 18 0.0014
460 HAEMORRHAGIC ANAEMIA 6 0.0014
461 MOUTH HAEMORRHAGE 10 0.0014
462 HAEMOGLOBIN DECREASED 140 0.0014
463 TACHYCARDIA 121 0.0014
464 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
465 ANAPHYLACTIC REACTION 75 0.0014
466 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
467 CEREBRAL INFARCTION 33 0.0013
468 HYPONATRAEMIA 76 0.0013
469 SINUS BRADYCARDIA 13 0.0013
470 TENDERNESS 14 0.0013
471 BRADYCARDIA 71 0.0013
472 ESCHERICHIA INFECTION 11 0.0013
473 BRONCHIECTASIS 9 0.0013
474 BONE MARROW FAILURE 27 0.0013
475 AUTOIMMUNE THYROIDITIS 5 0.0013
476 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
477 RENAL DISORDER 61 0.0013
478 IRON DEFICIENCY ANAEMIA 12 0.0013
479 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
480 EJECTION FRACTION DECREASED 20 0.0013
481 NEPHROPATHY 12 0.0013
482 HAEMORRHAGIC STROKE 10 0.0013
483 GASTROINTESTINAL HAEMORRHAGE 107 0.0013
484 FLANK PAIN 12 0.0013
485 SUBARACHNOID HAEMORRHAGE 13 0.0013
486 TORSADE DE POINTES 10 0.0013
487 BLOOD SODIUM DECREASED 24 0.0013
488 CARDIAC MURMUR 11 0.0013
489 COVID-19 PNEUMONIA 15 0.0013
490 DELIRIUM 44 0.0013
491 GASTRIC ULCER HAEMORRHAGE 7 0.0013
492 ATRIAL FIBRILLATION 123 0.0013
493 NEUTROPENIA 171 0.0013
494 OBESITY 20 0.0013
495 NON-SMALL CELL LUNG CANCER 6 0.0013
496 OSTEOPENIA 19 0.0013
497 INTESTINAL PERFORATION 14 0.0012
498 PETECHIAE 13 0.0012
499 PROCTALGIA 8 0.0012
500 COLITIS 47 0.0012
501 RESPIRATORY RATE INCREASED 11 0.0012
502 OEDEMA 67 0.0012
503 HEPATITIS ACUTE 8 0.0012
504 GRANULOCYTOPENIA 7 0.0012
505 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
506 POLYURIA 10 0.0012
507 BLOOD URIC ACID INCREASED 7 0.0012
508 DIABETIC NEUROPATHY 6 0.0012
509 ANAPHYLACTIC SHOCK 31 0.0012
510 POST PROCEDURAL COMPLICATION 23 0.0012
511 HAEMATURIA 41 0.0012
512 PULMONARY EMBOLISM 113 0.0012
513 UPPER GASTROINTESTINAL HAEMORRHAGE 20 0.0012
514 HYPOTHERMIA 12 0.0012
515 GALLBLADDER DISORDER 21 0.0012
516 PROCEDURAL COMPLICATION 9 0.0012
517 LACERATION 11 0.0012
518 LIVER FUNCTION TEST ABNORMAL 34 0.0012
519 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
520 JOINT EFFUSION 8 0.0012
521 BLOOD MAGNESIUM DECREASED 10 0.0012
522 METASTASES TO BONE 19 0.0012
523 TRANSFUSION 12 0.0011
524 DUODENAL ULCER 8 0.0011
525 C-REACTIVE PROTEIN INCREASED 41 0.0011
526 CANDIDA INFECTION 19 0.0011
527 INFUSION SITE EXTRAVASATION 7 0.0011
528 TRANSPLANT REJECTION 9 0.0011
529 RETINAL HAEMORRHAGE 8 0.0011
530 RED BLOOD CELL COUNT DECREASED 32 0.0011
531 DIVERTICULITIS 31 0.0011
532 LIVER FUNCTION TEST INCREASED 24 0.0011
533 ANAL INCONTINENCE 10 0.0011
534 CARDIAC FAILURE 89 0.0011
535 BRAIN OEDEMA 14 0.0011
536 INTRACRANIAL PRESSURE INCREASED 6 0.0011
537 HAEMORRHOIDS 21 0.0011
538 BURSITIS 13 0.0011
539 ANGIOPATHY 6 0.0011
540 OXYGEN SATURATION DECREASED 60 0.0011
541 PERITONITIS 22 0.0011
542 LEUKOPENIA 53 0.0011
543 VENTRICULAR EXTRASYSTOLES 11 0.0011
544 SPUTUM DISCOLOURED 10 0.0011
545 DRUG-INDUCED LIVER INJURY 33 0.0011
546 LIPASE INCREASED 8 0.0010
547 INCONTINENCE 11 0.0010
548 APHAGIA 5 0.0010
549 COLITIS ISCHAEMIC 7 0.0010
550 POSTOPERATIVE WOUND INFECTION 7 0.0010
551 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
552 CEREBRAL HAEMORRHAGE 37 0.0010
553 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 8 0.0010
554 PRODUCT LABEL CONFUSION 6 0.0010
555 ABDOMINAL PAIN LOWER 26 0.0010
556 APNOEA 8 0.0010
557 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
558 BLOOD PRESSURE DECREASED 68 0.0010
559 CROHN'S DISEASE 7 0.0010
560 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
561 OEDEMA PERIPHERAL 124 0.0010
562 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
563 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
564 ANOREXIA 13 0.0010
565 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
566 PULMONARY MASS 15 0.0010
567 OESOPHAGITIS 11 0.0010
568 URINARY TRACT INFECTION 171 0.0010
569 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
570 TOOTH FRACTURE 11 0.0010
571 PLATELET COUNT INCREASED 13 0.0010
572 TYPE 1 DIABETES MELLITUS 6 0.0010
573 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
574 HEPATITIS B 6 0.0010
575 NO THERAPEUTIC RESPONSE 12 0.0010
576 POST PROCEDURAL INFECTION 8 0.0010
577 NEUTROPHIL COUNT INCREASED 10 0.0010
578 GRAND MAL CONVULSION 9 0.0010
579 RESPIRATORY DISORDER 29 0.0010
580 MUSCULOSKELETAL CHEST PAIN 15 0.0010
581 DERMATITIS BULLOUS 7 0.0010
582 DRUG LEVEL INCREASED 16 0.0010
583 DEFORMITY 9 0.0010
584 LYMPHOCYTE COUNT DECREASED 17 0.0010
585 CONVULSION 55 0.0010
586 APLASTIC ANAEMIA 5 0.0010
587 DYSPNOEA EXERTIONAL 36 0.0010
588 ORAL DISORDER 7 0.0010
589 PSYCHIATRIC SYMPTOM 7 0.0009
590 UTERINE PERFORATION 8 0.0009
591 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
592 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
593 SCAR 16 0.0009
594 CHILLS 109 0.0009
595 OSTEONECROSIS OF JAW 23 0.0009
596 HYPERTHERMIA 7 0.0009
597 BEDRIDDEN 12 0.0009
598 HEPATIC CIRRHOSIS 17 0.0009
599 TRANSAMINASES INCREASED 20 0.0009
600 NERVE INJURY 10 0.0009
601 BRAIN INJURY 9 0.0009
602 FACIAL PAIN 8 0.0009
603 LACTIC ACIDOSIS 29 0.0009
604 PERITONITIS BACTERIAL 9 0.0009
605 MUCOSAL INFLAMMATION 23 0.0009
606 INFUSION RELATED REACTION 58 0.0009
607 GASTRITIS 23 0.0009
608 RESPIRATORY ARREST 24 0.0009
609 URINARY RETENTION 29 0.0009
610 ENCEPHALITIS 6 0.0009
611 RHABDOMYOLYSIS 36 0.0009
612 HYPERTRANSAMINASAEMIA 6 0.0009
613 LOCAL SWELLING 15 0.0009
614 LETHARGY 49 0.0009
615 ACUTE MYOCARDIAL INFARCTION 25 0.0008
616 BRONCHOSPASM 12 0.0008
617 PRODUCTIVE COUGH 40 0.0008
618 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
619 PERICARDITIS 14 0.0008
620 CHOLESTASIS 16 0.0008
621 DEHYDRATION 111 0.0008
622 INFUSION SITE ERYTHEMA 7 0.0008
623 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
624 APHASIA 25 0.0008
625 UNEVALUABLE EVENT 62 0.0008
626 HAEMATOMA 21 0.0008
627 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
628 HEPATOTOXICITY 18 0.0008
629 PHARYNGITIS 10 0.0008
630 ACUTE HEPATIC FAILURE 11 0.0008
631 SKIN INFECTION 9 0.0008
632 FISTULA 9 0.0008
633 GROIN PAIN 7 0.0008
634 IMMUNOSUPPRESSION 7 0.0008
635 EMPHYSEMA 8 0.0008
636 PURPURA 7 0.0008
637 VIRAL INFECTION 26 0.0008
638 MYOSITIS 7 0.0008
639 LYMPHOMA 12 0.0008
640 EMOTIONAL DISTRESS 93 0.0008
641 INFECTION 111 0.0008
642 EXOSTOSIS 7 0.0008
643 BLOOD POTASSIUM DECREASED 23 0.0008
644 LYMPHADENOPATHY 27 0.0008
645 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
646 STOMATITIS 46 0.0008
647 CONFUSIONAL STATE 122 0.0008
648 HEPATIC STEATOSIS 14 0.0008
649 BRONCHITIS 55 0.0007
650 PAIN IN JAW 21 0.0007
651 DYSPHAGIA 70 0.0007
652 SKIN ULCER 19 0.0007
653 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
654 HICCUPS 6 0.0007
655 RIB FRACTURE 15 0.0007
656 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
657 ABDOMINAL PAIN 167 0.0007
658 PHARYNGEAL OEDEMA 11 0.0007
659 WHEEZING 42 0.0007
660 MYOCARDIAL ISCHAEMIA 8 0.0007
661 HYPOGLYCAEMIA 34 0.0007
662 CHOLECYSTECTOMY 8 0.0007
663 RASH ERYTHEMATOUS 33 0.0007
664 ORTHOSTATIC HYPOTENSION 12 0.0007
665 HYPOTHYROIDISM 22 0.0007
666 TOOTH ABSCESS 7 0.0007
667 VASCULITIS 8 0.0007
668 DERMATITIS 14 0.0007
669 DRUG TOXICITY 9 0.0007
670 OSTEOARTHRITIS 28 0.0007
671 HEPATIC ENZYME INCREASED 45 0.0007
672 AORTIC ANEURYSM 5 0.0007
673 RESPIRATORY DEPRESSION 8 0.0007
674 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
675 DECREASED ACTIVITY 7 0.0006
676 INJECTION SITE EXTRAVASATION 8 0.0006
677 ATRIOVENTRICULAR BLOCK 5 0.0006
678 MASS 9 0.0006
679 DISEASE PROGRESSION 76 0.0006
680 DIARRHOEA HAEMORRHAGIC 6 0.0006
681 SYNCOPE 64 0.0006
682 SQUAMOUS CELL CARCINOMA 6 0.0006
683 LYMPHOPENIA 9 0.0006
684 DENTAL CARIES 7 0.0006
685 PROTEINURIA 12 0.0006
686 HAEMATEMESIS 16 0.0006
687 SLEEP APNOEA SYNDROME 12 0.0006
688 DRUG RESISTANCE 16 0.0006
689 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
690 RASH 269 0.0006
691 ORAL HERPES 12 0.0006
692 LUNG DISORDER 30 0.0006
693 IMPAIRED HEALING 20 0.0006
694 HYPERTENSION 129 0.0006
695 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
696 PANCREATITIS 32 0.0006
697 MALIGNANT NEOPLASM PROGRESSION 62 0.0006
698 BONE DISORDER 11 0.0006
699 FUNGAL INFECTION 20 0.0006
700 DRUG LEVEL DECREASED 6 0.0006
701 HEPATITIS 15 0.0006
702 TENDONITIS 9 0.0006
703 HEART RATE IRREGULAR 13 0.0006
704 EPISTAXIS 43 0.0006
705 URINARY INCONTINENCE 17 0.0006
706 DEAFNESS 15 0.0006
707 DYSPNOEA 324 0.0006
708 RASH PRURITIC 31 0.0006
709 DYSURIA 21 0.0006
710 GENERAL PHYSICAL HEALTH DETERIORATION 66 0.0006
711 ARRHYTHMIA 27 0.0006
712 METASTASES TO LIVER 10 0.0006
713 RETCHING 12 0.0006
714 BREAST CANCER METASTATIC 6 0.0006
715 ANXIETY 159 0.0006
716 DERMATITIS ALLERGIC 7 0.0006
717 ABDOMINAL DISTENSION 58 0.0006
718 SKIN LACERATION 6 0.0006
719 PALLOR 15 0.0006
720 GASTROENTERITIS 8 0.0005
721 DIARRHOEA 353 0.0005
722 HAEMORRHAGE 56 0.0005
723 RECTAL HAEMORRHAGE 23 0.0005
724 GASTROOESOPHAGEAL REFLUX DISEASE 43 0.0005
725 CIRCULATORY COLLAPSE 9 0.0005
726 HAEMATOCHEZIA 29 0.0005
727 MOUTH ULCERATION 11 0.0005
728 PULMONARY FIBROSIS 10 0.0005
729 SINUS CONGESTION 7 0.0005
730 IMPAIRED GASTRIC EMPTYING 7 0.0005
731 OSTEOPOROSIS 21 0.0005
732 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
733 LABORATORY TEST ABNORMAL 15 0.0005
734 FAECES DISCOLOURED 11 0.0005
735 TYPE 2 DIABETES MELLITUS 17 0.0005
736 COMA 24 0.0005
737 MYOCLONUS 6 0.0005
738 COORDINATION ABNORMAL 7 0.0005
739 NEPHROLITHIASIS 23 0.0005
740 VOMITING 235 0.0005
741 DECREASED APPETITE 115 0.0005
742 PRESYNCOPE 12 0.0005
743 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
744 CYTOPENIA 6 0.0005
745 COUGH 137 0.0005
746 CONJUNCTIVITIS 9 0.0005
747 TOOTH LOSS 10 0.0005
748 DISORIENTATION 19 0.0005
749 DYSARTHRIA 18 0.0005
750 MUSCLE TWITCHING 11 0.0005
751 GASTRIC ULCER 9 0.0005
752 HEMIPARESIS 8 0.0005
753 CYSTITIS 15 0.0005
754 HERPES ZOSTER 27 0.0005
755 ASTHENIA 176 0.0005
756 ROTATOR CUFF SYNDROME 6 0.0005
757 INFUSION SITE PAIN 6 0.0005
758 WOUND 13 0.0005
759 PRURITUS GENERALISED 10 0.0005
760 SWELLING FACE 30 0.0005
761 RESPIRATORY TRACT INFECTION 12 0.0005
762 BACK PAIN 107 0.0005
763 KIDNEY INFECTION 9 0.0005
764 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
765 CONDITION AGGRAVATED 137 0.0005
766 ISCHAEMIC STROKE 8 0.0004
767 CHEST PAIN 83 0.0004
768 MALIGNANT MELANOMA 6 0.0004
769 QUALITY OF LIFE DECREASED 6 0.0004
770 CONSTIPATION 97 0.0004
771 CHROMATURIA 10 0.0004
772 TOOTHACHE 8 0.0004
773 NEUROPATHY PERIPHERAL 42 0.0004
774 PERIPHERAL COLDNESS 6 0.0004
775 PLASMA CELL MYELOMA 17 0.0004
776 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
777 DIABETES MELLITUS 33 0.0004
778 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
779 DEVICE OCCLUSION 6 0.0004
780 FRACTURE 8 0.0004
781 LIP SWELLING 14 0.0004
782 PARALYSIS 6 0.0004
783 CONTUSION 40 0.0004
784 LOCALISED INFECTION 10 0.0004
785 BLISTER 23 0.0004
786 PAIN 250 0.0004
787 MUSCULOSKELETAL DISCOMFORT 7 0.0004
788 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
789 SINUS DISORDER 8 0.0004
790 IMMUNODEFICIENCY 6 0.0004
791 ORAL PAIN 9 0.0004
792 OSTEONECROSIS 13 0.0004
793 DEMENTIA 11 0.0004
794 NASAL CONGESTION 23 0.0004
795 GOUT 7 0.0004
796 BASAL CELL CARCINOMA 6 0.0004
797 HEAD INJURY 12 0.0004
798 ULCER 6 0.0004
799 SCIATICA 6 0.0004
800 NEOPLASM PROGRESSION 13 0.0004
801 FLUID RETENTION 19 0.0004
802 NIGHT SWEATS 12 0.0004
803 NAUSEA 293 0.0004
804 MENTAL DISORDER 16 0.0004
805 AGITATION 27 0.0004
806 LIVER INJURY 9 0.0004
807 URTICARIA 61 0.0004
808 MUSCULOSKELETAL PAIN 19 0.0004
809 MUSCULAR WEAKNESS 41 0.0004
810 THROMBOSIS 29 0.0004
811 MEDICATION ERROR 20 0.0004
812 SKIN DISORDER 12 0.0004
813 POLLAKIURIA 15 0.0004
814 DRUG INTERACTION 57 0.0004
815 FACE OEDEMA 6 0.0004
816 RESTLESSNESS 13 0.0004
817 ERYTHEMA 72 0.0003
818 FALL 116 0.0003
819 TREATMENT NONCOMPLIANCE 19 0.0003
820 ILL-DEFINED DISORDER 21 0.0003
821 FEEDING DISORDER 7 0.0003
822 DYSKINESIA 14 0.0003
823 TREMOR 57 0.0003
824 HEART RATE DECREASED 12 0.0003
825 WEIGHT DECREASED 95 0.0003
826 OROPHARYNGEAL PAIN 31 0.0003
827 BLOOD PRESSURE FLUCTUATION 8 0.0003
828 FREQUENT BOWEL MOVEMENTS 9 0.0003
829 THROAT TIGHTNESS 9 0.0003
830 CHEST DISCOMFORT 34 0.0003
831 HALLUCINATION 25 0.0003
832 SWELLING 31 0.0003
833 RESTLESS LEGS SYNDROME 6 0.0003
834 EPILEPSY 10 0.0003
835 SKIN DISCOLOURATION 15 0.0003
836 DEPRESSION 74 0.0003
837 HEART RATE INCREASED 32 0.0003
838 FEMUR FRACTURE 10 0.0003
839 VAGINAL HAEMORRHAGE 14 0.0003
840 NERVOUS SYSTEM DISORDER 10 0.0003
841 HYPERHIDROSIS 41 0.0003
842 FOOT FRACTURE 6 0.0003
843 ANGIOEDEMA 14 0.0003
844 ANGINA PECTORIS 9 0.0003
845 SINUSITIS 32 0.0003
846 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
847 SKIN EXFOLIATION 26 0.0003
848 DIPLOPIA 8 0.0003
849 MYELOSUPPRESSION 11 0.0003
850 SPEECH DISORDER 16 0.0003
851 LOSS OF CONSCIOUSNESS 39 0.0003
852 NECK PAIN 17 0.0003
853 SEIZURE 35 0.0003
854 COGNITIVE DISORDER 14 0.0003
855 GAIT INABILITY 10 0.0003
856 INTESTINAL OBSTRUCTION 11 0.0003
857 SKIN LESION 8 0.0003
858 DIABETIC KETOACIDOSIS 7 0.0003
859 BONE PAIN 17 0.0003
860 CEREBROVASCULAR ACCIDENT 49 0.0003
861 PROCEDURAL PAIN 8 0.0003
862 SWOLLEN TONGUE 9 0.0003
863 NEURALGIA 7 0.0003
864 INFLUENZA 32 0.0003
865 RASH MACULAR 10 0.0003
866 HYPERSENSITIVITY 53 0.0003
867 PALPITATIONS 33 0.0003
868 DYSSTASIA 8 0.0003
869 DYSPHONIA 16 0.0003
870 PERIPHERAL SWELLING 42 0.0003
871 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
872 THERAPY NON-RESPONDER 12 0.0003
873 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
874 FLUSHING 27 0.0003
875 MYOCARDIAL INFARCTION 46 0.0003
876 ROAD TRAFFIC ACCIDENT 11 0.0003
877 ASTHMA 29 0.0003
878 GAIT DISTURBANCE 48 0.0003
879 MOBILITY DECREASED 18 0.0003
880 MOVEMENT DISORDER 8 0.0002
881 HIP FRACTURE 8 0.0002
882 DISCOMFORT 15 0.0002
883 GASTROINTESTINAL DISORDER 22 0.0002
884 COVID-19 43 0.0002
885 ABASIA 6 0.0002
886 MALAISE 106 0.0002
887 PRURITUS 92 0.0002
888 SOMNOLENCE 48 0.0002
889 DYSPEPSIA 23 0.0002
890 NERVOUSNESS 12 0.0002
891 FLATULENCE 13 0.0002
892 SEDATION 6 0.0002
893 JOINT STIFFNESS 6 0.0002
894 BLOOD GLUCOSE INCREASED 43 0.0002
895 HYPOAESTHESIA 34 0.0002
896 EMOTIONAL DISORDER 7 0.0002
897 EXPOSURE DURING PREGNANCY 14 0.0002
898 FATIGUE 175 0.0002
899 ABDOMINAL PAIN UPPER 46 0.0002
900 BONE DENSITY DECREASED 7 0.0002
901 PAIN OF SKIN 6 0.0002
902 DIZZINESS 111 0.0002
903 LIMB INJURY 6 0.0002
904 PAIN IN EXTREMITY 65 0.0002
905 TOXICITY TO VARIOUS AGENTS 37 0.0002
906 ACCIDENTAL OVERDOSE 8 0.0002
907 DEATH 187 0.0002
908 RHINORRHOEA 14 0.0002
909 INSOMNIA 57 0.0002
910 CARDIAC DISORDER 20 0.0002
911 EXPIRED PRODUCT ADMINISTERED 7 0.0002
912 VISUAL IMPAIRMENT 26 0.0002
913 MULTIPLE SCLEROSIS 10 0.0002
914 PANCREATIC CARCINOMA 6 0.0002
915 PRODUCT USE IN UNAPPROVED INDICATION 50 0.0002
916 WEIGHT INCREASED 45 0.0002
917 MYALGIA 34 0.0002
918 OFF LABEL USE 173 0.0002
919 PARAESTHESIA 31 0.0002
920 DRUG ADMINISTRATION ERROR 6 0.0002
921 THERAPY CESSATION 10 0.0002
922 LUNG NEOPLASM MALIGNANT 8 0.0002
923 DISEASE RECURRENCE 9 0.0002
924 BLOOD GLUCOSE DECREASED 9 0.0002
925 HEADACHE 117 0.0002
926 BALANCE DISORDER 16 0.0002
927 ARTHROPATHY 10 0.0002
928 ABDOMINAL DISCOMFORT 30 0.0002
929 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
930 ARTHRALGIA 73 0.0002
931 VISION BLURRED 24 0.0002
932 MEMORY IMPAIRMENT 24 0.0002
933 DEPRESSED MOOD 9 0.0002
934 CRYING 6 0.0002
935 PANIC ATTACK 6 0.0002
936 VERTIGO 10 0.0002
937 HOSPITALISATION 25 0.0002
938 EYE SWELLING 6 0.0002
939 PRODUCT USE ISSUE 30 0.0002
940 MUSCLE SPASMS 29 0.0002
941 BLOOD PRESSURE INCREASED 24 0.0002
942 ILLNESS 16 0.0002
943 DRUG INEFFECTIVE 203 0.0002
944 AMNESIA 10 0.0002
945 CATARACT 9 0.0002
946 FEELING HOT 9 0.0001
947 TREATMENT FAILURE 12 0.0001
948 DRY EYE 7 0.0001
949 ARTHRITIS 11 0.0001
950 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
951 INFLAMMATION 7 0.0001
952 DRY MOUTH 11 0.0001
953 COLITIS ULCERATIVE 6 0.0001
954 ECZEMA 7 0.0001
955 TINNITUS 6 0.0001
956 NO ADVERSE EVENT 23 0.0001
957 MUSCULOSKELETAL STIFFNESS 11 0.0001
958 BLINDNESS 5 0.0001
959 ADVERSE DRUG REACTION 11 0.0001
960 DYSGEUSIA 9 0.0001
961 FEELING ABNORMAL 29 0.0001
962 ALOPECIA 23 0.0001
963 JOINT SWELLING 14 0.0001
964 INTENTIONAL PRODUCT MISUSE 10 0.0001
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
966 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
967 INFLUENZA LIKE ILLNESS 9 0.0001
968 OVERDOSE 23 0.0001
969 EYE PAIN 6 0.0001
970 INJECTION SITE ERYTHEMA 13 0.0001
971 DRUG INTOLERANCE 10 0.0001
972 SLEEP DISORDER 7 0.0001
973 THERAPEUTIC RESPONSE DECREASED 6 0.0001
974 NASOPHARYNGITIS 18 0.0001
975 PRODUCT DOSE OMISSION 6 0.0001
976 DRY SKIN 12 0.0001
977 NEOPLASM MALIGNANT 6 0.0001
978 PRODUCT QUALITY ISSUE 12 0.0001
979 BURNING SENSATION 6 0.0001
980 THERAPY INTERRUPTED 6 0.0001
981 MIGRAINE 8 0.0001
982 SKIN BURNING SENSATION 6 0.0001
983 HOT FLUSH 6 0.0001
984 SUICIDAL IDEATION 7 0.0001
985 INJECTION SITE HAEMORRHAGE 6 0.0001
986 PROSTATE CANCER 6 0.0001
987 DRUG ABUSE 6 0.0001
988 INCORRECT DOSE ADMINISTERED 16 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
990 DRUG DOSE OMISSION 11 0.0001
991 ADVERSE EVENT 6 0.0001
992 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
993 PSORIASIS 6 0.0000
994 INJECTION SITE PAIN 11 0.0000
995 PRODUCT DOSE OMISSION ISSUE 10 0.0000